WALTHAM, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders, announced today that Dr. Paul Sohmer, BG Medicine's President and CEO, will be presenting at the Baird 2013 Health Care Conference on September 10, 2013, at The New York Palace, beginning at 2:20 PM Eastern Time (ET).
Audio and slides of BG Medicine's presentation will be webcast at: http://wsw.com/webcast/baird35/BGMD . The webcast will be archived for 30 days following the live presentation on BG Medicine's Investor Relations website at ir.BG-medicine.com.
About BG MedicineBG Medicine, Inc. (Nasdaq:BGMD) is a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit www.BG-medicine.com and www.galectin-3.com . The BG Medicine Inc. logo is available for download here
CONTACT: Chuck Abdalian EVP & Chief Financial Officer (781) 434-0210
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV